<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01872494</url>
  </required_header>
  <id_info>
    <org_study_id>local anaesthetic</org_study_id>
    <nct_id>NCT01872494</nct_id>
  </id_info>
  <brief_title>The Impact of Local Analgesia for Postoperative Analgesia in Posterior Thoracolumbar Operation</brief_title>
  <official_title>Pain Treatment in Posterior Thoracolumbar Operation a Randomized Study to Assess the Effect of Local Analgesia After Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou General Hospital of Guangzhou Military Command</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou General Hospital of Guangzhou Military Command</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Posterior thoracolumbar operation always chooses general anesthesia. Due to surgical trauma
      and rich periosteum and joint capsule innervation, patients after general anesthesia
      immediately feel acute pain.The use of appropriate postoperative analgesia in patients with
      thoracolumbar surgery is beneficial to postoperative recovery. Infusions of local anaesthetic
      via multilumen catheters that deliver directly to wound sites have been used for
      postoperative analgesia in procedures. Reducing the morbidity from both pain and nausea will
      make the mode of analgesia a better tolerated and more palatable option for patients. The aim
      of this study is to examine the effects of using local anaesthetic infusion catheters
      following posterior thoracolumbar surgery, and compares the outcomes of patients managed
      using intravenous analgesia pump infusion of systemic opioids.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All 71 adult patients were prospectively included and randomized to either the local (L)
      group (n=35) or the intravenous (V) group (n=36) by using a random number table: the test
      group were treated with local analgesia infusion pump of 0.33% ropivacaine through the wound
      for postoperative analgesia, while the control group were treated with intravenous analgesia
      pump infusion of flurbiprofen axetil,palonosetron, pentazocine. At 2, 4, 6, 12, 24, 36, 48
      hours after operation, postoperative pain visual analogue scale(VAS) scores and sedation
      Ramsay scores were used to evaluate the level of pain and sedation, and investigators
      documented the comprehensive evaluation of patients with pain control system, and the
      incidence of adverse reactions. At 24, 48 hours investigators observed the wound whether
      inflammation and exudation or not, and the removal of penetration catheter sent to clinical
      laboratory for bacterial culture. Investigators also recorded the length of time to discharge
      and called to ask pain conditions at the first 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>48 hours postoperation</time_frame>
    <description>Up to 48 hours after operation,postoperative pain visual analogue scale(VAS) scores are used to evaluate the level of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sedation</measure>
    <time_frame>48 hours postoperation</time_frame>
    <description>At 2, 4, 6, 12, 24, 36, 48 hours after operation,sedation Ramsay scores are used to evaluate the level of sedation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comprehensive evaluation</measure>
    <time_frame>48 hours postoperation</time_frame>
    <description>Investigators document the comprehensive evaluation of patients with pain control system,including the incidence of adverse reactions.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Local</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group uses local analgesia infusion pump of 0.33% ropivacaine 250ml through the wound for postoperative analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group is treated with intravenous analgesia pump infusion of flurbiprofen axetil 150mg,palonosetron 0.5mg,pentazocine 240mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>local</intervention_name>
    <description>This group uses local analgesia infusion pump of 0.33% ropivacaine 250ml through the wound for postoperative analgesia.</description>
    <arm_group_label>Local</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intravenous</intervention_name>
    <description>This group is treated with intravenous analgesia pump infusion of flurbiprofen axetil 150mg,palonosetron 0.5mg,pentazocine 240mg.</description>
    <arm_group_label>intravenous</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.33% ropivacaine 250ml</intervention_name>
    <arm_group_label>Local</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>flurbiprofen axetil 150mg,palonosetron 0.5mg,pentazocine 240mg.</intervention_name>
    <arm_group_label>intravenous</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ASA Ⅰ ~ Ⅱ patient undergoing elective posterior thoracolumbar operation

          2. between 18 and 70 years of age

        Exclusion Criteria:

          1. A history of cardiopulmonary disease, liver and kidney dysfunction, abnormal
             coagulation

          2. Preoperative use of analgesic drugs

          3. A allergy history of ropivacaine and polyurethane material
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Guangzhou Military Region General Hospital, Department of Anesthesiology</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510010</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Jirarattanaphochai K, Jung S, Thienthong S, Krisanaprakornkit W, Sumananont C. Peridural methylprednisolone and wound infiltration with bupivacaine for postoperative pain control after posterior lumbar spine surgery: a randomized double-blinded placebo-controlled trial. Spine (Phila Pa 1976). 2007 Mar 15;32(6):609-16; discussion 617.</citation>
    <PMID>17413463</PMID>
  </reference>
  <reference>
    <citation>Mekawy N M, Badawy S S I, Sakr S A. Role of postoperative continuous subfascial bupivacaine infusion after posterior cervical laminectomy: Randomized control study. Egyptian J Anaesth, 2012, 28(1): 83-88.</citation>
  </reference>
  <reference>
    <citation>Aguirre J, Baulig B, Dora C, Ekatodramis G, Votta-Velis G, Ruland P, Borgeat A. Continuous epicapsular ropivacaine 0.3% infusion after minimally invasive hip arthroplasty: a prospective, randomized, double-blinded, placebo-controlled study comparing continuous wound infusion with morphine patient-controlled analgesia. Anesth Analg. 2012 Feb;114(2):456-61. doi: 10.1213/ANE.0b013e318239dc64. Epub 2011 Nov 10. Erratum in: Anesth Analg. 2013 Jun;116(6):1394.</citation>
    <PMID>22075018</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2013</study_first_submitted>
  <study_first_submitted_qc>June 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2013</study_first_posted>
  <last_update_submitted>May 1, 2014</last_update_submitted>
  <last_update_submitted_qc>May 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou General Hospital of Guangzhou Military Command</investigator_affiliation>
    <investigator_full_name>bo xu</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>Local analgesia system</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Analgesic efficacy after operation</keyword>
  <keyword>Postoperative</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Pentazocine</mesh_term>
    <mesh_term>Flurbiprofen</mesh_term>
    <mesh_term>Flurbiprofen axetil</mesh_term>
    <mesh_term>Palonosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

